Abstract
This JAMA Forum discusses implementation of the Medicare drug pricing provision of the Inflation Reduction Act of 2022 and ways the new frameworks can be tweaked to achieve the desired public health goals.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
